Antiphospholipid syndrome (APS)
Clinical trials for Antiphospholipid syndrome (APS) explained in plain language.
Never miss a new study
Get alerted when new Antiphospholipid syndrome (APS) trials appear
Sign up with your email to follow new studies for Antiphospholipid syndrome (APS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame antibodies in rare clotting disorder
Disease control CompletedThis phase 2 trial tested whether the drug telitacicept can reduce levels of harmful antibodies in 20 people with antiphospholipid syndrome, a condition that raises the risk of blood clots. Participants received either telitacicept plus standard care or standard care alone for 48…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Gut bacteria eyed as hidden trigger in autoimmune clotting disorder
Knowledge-focused CompletedResearchers at Yale University are studying whether certain gut bacteria are linked to the autoantibodies that drive antiphospholipid syndrome, an autoimmune disorder that causes dangerous blood clots. The study follows 16 adults, including patients with the syndrome, people who …
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC